-
A Highly Reproducible Cell Migration Screening Assay
6/22/2009
amsbio has announced a new generation of novel two-dimensional cell-based assay kits developed for reproducibly screening test compounds that may stimulate or inhibit adherent cell migration.
-
Nanocrystals Reveal Activity Within Cells
6/17/2009
Researchers at the U.S. Department of Energy’s (DOE) Lawrence Berkeley National Laboratory have created bright, stable and bio-friendly nanocrystals that act as individual investigators of activity within a cell. These ideal light emitting probes represent a significant step in scrutinizing the behaviors of proteins and other components in complex systems such as a living cell.
-
Direct Elemental (CHN) Analysis Of Environmental Filter Samples
6/12/2009
Exeter Analytical Inc. has published an application note describing direct determination of total Carbon, Hydrogen and Nitrogen in environmental air and water filter samples
-
FDA Forms Transparency Task Force
6/4/2009
The U.S. Food and Drug Administration (FDA) recently announced the formation of a task force to develop recommendations for enhancing the transparency of the agency’s operations and decision-making process.
-
Cornerstone Pharmaceuticals Initiates Phase I/II Combination Therapy Clinical Trial Of CPI-613 For Treatment Of Pancreatic Cancer
5/28/2009
Cornerstone Pharmaceuticals, Inc., a privately-held pharmaceutical company, announced today that it has begun a phase I/II clinical trial of CPI-613, the initial candidate to emerge from the company's Altered Energy Metabolism Directed technology platform.
-
Johnson & Johnson Announces Definitive Agreement To Acquire Cougar Biotechnology, Inc.
5/25/2009
Johnson & Johnson and Cougar Biotechnology, Inc., a development stage biopharmaceutical company with a specific focus on oncology, recently announced a definitive agreement whereby Cougar Biotechnology will be acquired for approximately $1.0B in a cash tender offer.
-
Breakthrough In Radiotherapy Promises Targeted Cancer Treatment
5/20/2009
Current radiation therapy treatment damages a patient’s healthy tissue as well as eradicating the tumour it is intended to destroy, making the treatment especially invasive and often causing nasty side effects.
-
Flow Of Potassium Into Cells Implicated In Schizophrenia Blocking Errant Protein Could Stem Runaway Brain Activity In Psychosis
5/6/2009
A study on schizophrenia has implicated machinery that maintains the flow of potassium in cells and revealed a potential molecular target for new treatments.
-
FDA, FTC Warn Public Of Fraudulent 2009 H1N1 Influenza Products
5/5/2009
The U.S. Food and Drug Administration and the Federal Trade Commission are alerting the public to be wary of Internet sites and other promotions for products that claim to diagnose, prevent, mitigate, treat or cure the 2009 H1N1 influenza virus.
-
Autism Genes Discovered; Help Shape Connections Among Brain Cells
5/5/2009
A research team has connected more of the intricate pieces of the autism puzzle, with two studies that identify genes with important contributions to the disorder.